Highlights Dancann Pharma A/S

Equities

DANCAN

DK0061410487

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
0.06 ^DKK	+7.14%		+40.19%	+100.00%

Mar. 29	Dancann Pharma Plans Up to DKK19 Million Rights Issue	MT
Feb. 28	DanCann Pharma Notes Cannabis Legalization in Germany as Shares Surge	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DanCann Pharma Notes Cannabis Legalization in Germany as Shares Surge	Feb. 28	MT
Dancann Pharma A/S Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
Dancann Pharma A/S Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Dancann Pharma A/S Provides Revenue Guidance for the Financial Year 2025	Dec. 20	CI
Dancann Pharma A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 30	CI
Dancann Pharma A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-31	CI
DanCann Mulls Sale of Production Facility Amid Shift in Business Strategy; Shares Plunge 13%	23-08-31	MT
Dancann Pharma A/S' Pre-Validation Batches Meets European Standards, Paving the Path for Final Product Approval	23-06-01	CI
Dancann Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-31	CI
Dancann Pharma A/S Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-12	CI
DanCann Pharma to Distribute Prescription Cannabinoid-based Medications in Scandinavian Markets	23-05-09	MT
Dancann Pharma A/S Provides Positive Insight on Progress of Cannabis Bulk Product Approval	23-03-14	CI
Dancann Pharma A/S and Canngros Aps Open Office in Odense	23-02-23	CI
Dancann Pharma Unit Receives Regulatory Approval for New Facility in Denmark	22-12-13	MT
DanCann Pharma Falls 20% In Germany amid US Debut	22-12-05	MT
Denmark's DanCann Pharma Wins EU Approval For Manufacturing Facilities	22-12-02	MT
Dancann Pharma Sees EU Approval For Manufacturing Facilities Before Year-end	22-11-08	MT
Dancann Pharma A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-04	CI
Dancann Pharma A/S Signs Binding Agreement with Polish Company Storkpharm Worth More Than DKK 40 Million	22-11-03	CI
DanCann Pharma, Horsted Institute Specialist Team Up on Medical Cannabis Study	22-09-12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Dancann Pharma A/S

Equities

DANCAN

DK0061410487

Highlights

Filters